SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-028658
Filing Date
2019-12-06
Accepted
2019-12-06 15:25:25
Documents
1
Period of Report
2019-12-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3440
  Complete submission text file 0000899243-19-028658.txt   4751
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Reitan Colleen F (Reporting) CIK: 0001740730 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 191272919